UK markets closed

Capricor Therapeutics, Inc. (CAPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.8200-0.1200 (-2.43%)
As of 03:51PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3344
Avg. Estimate-0.11-0.29-0.960.1
Low estimate-0.26-0.32-1.36-1.21
High estimate0.03-0.26-0.751.44
Year ago EPS-0.31-0.29-0.83-0.96
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate9.7M4.41M28.53M119.36M
Low estimate5M3.92M27.2M22.5M
High estimate14.1M5M30M185M
Year ago sales2.99M3.92M25.18M28.53M
Sales growth (year/est)224.80%12.60%13.30%318.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.32-0.35-0.29-0.09
Actual EPS-0.31-0.29-0.25-0.02
Difference0.010.060.040.07
Surprise %3.10%17.10%13.80%77.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.11-0.29-0.960.1
7 days ago-0.11-0.29-0.960.1
30 days ago-0.11-0.29-0.960.1
60 days ago-0.3-0.3-1.05-0.49
90 days ago-0.3-0.3-1.05-0.49
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCAPRIndustrySector(s)S&P 500
Current qtr.64.50%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year-15.70%N/AN/AN/A
Next year110.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A